Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1948 1
1949 2
1950 1
1957 1
1964 2
1968 1
1969 3
1970 2
1972 2
1973 6
1975 5
1976 4
1977 6
1978 4
1980 5
1981 7
1982 8
1983 7
1984 7
1985 6
1986 7
1987 3
1990 2
1991 1
1992 1
1995 1
1996 1
1997 1
1998 2
2000 2
2005 3
2006 1
2007 1
2008 3
2009 1
2010 4
2011 2
2012 3
2013 3
2014 6
2015 8
2016 14
2017 8
2018 2
2019 9
2020 6
2021 11
2022 8
2023 16
2024 14
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Results by year

Filters applied: . Clear all
Page 1
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Schöder H, Wan S, Wester HJ, Hope TA, Herrmann K. Fendler WP, et al. Among authors: osborne jr. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. Epub 2023 Jan 5. Eur J Nucl Med Mol Imaging. 2023. PMID: 36604326 Free PMC article.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: osborne jr. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
DNMT3A mutations in acute myeloid leukemia.
Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, Osborne JR, Lin L, O'Laughlin M, McMichael JF, Delehaunty KD, McGrath SD, Fulton LA, Magrini VJ, Vickery TL, Hundal J, Cook LL, Conyers JJ, Swift GW, Reed JP, Alldredge PA, Wylie T, Walker J, Kalicki J, Watson MA, Heath S, Shannon WD, Varghese N, Nagarajan R, Westervelt P, Tomasson MH, Link DC, Graubert TA, DiPersio JF, Mardis ER, Wilson RK. Ley TJ, et al. Among authors: osborne jr. N Engl J Med. 2010 Dec 16;363(25):2424-33. doi: 10.1056/NEJMoa1005143. Epub 2010 Nov 10. N Engl J Med. 2010. PMID: 21067377 Free PMC article.
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology.
Mosconi L, Nerattini M, Matthews DC, Jett S, Andy C, Williams S, Yepez CB, Zarate C, Carlton C, Fauci F, Ajila T, Pahlajani S, Andrews R, Pupi A, Ballon D, Kelly J, Osborne JR, Nehmeh S, Fink M, Berti V, Dyke JP, Brinton RD. Mosconi L, et al. Among authors: osborne jr. Sci Rep. 2024 Jun 20;14(1):12680. doi: 10.1038/s41598-024-62820-7. Sci Rep. 2024. PMID: 38902275 Free PMC article.
Advances in PSMA-Targeted Radionuclide Therapeutics.
Ruder S, Ricaurte-Fajardo A, Sun M, Huicochea Castellanos S, Osborne JR, Tagawa ST. Ruder S, et al. Among authors: osborne jr. Curr Treat Options Oncol. 2025 Apr;26(4):291-301. doi: 10.1007/s11864-025-01296-7. Epub 2025 Mar 26. Curr Treat Options Oncol. 2025. PMID: 40138150 Review.
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.
Tagawa ST, Thomas C, Sartor AO, Sun M, Stangl-Kremser J, Bissassar M, Vallabhajosula S, Huicochea Castellanos S, Nauseef JT, Sternberg CN, Molina A, Ballman K, Nanus DM, Osborne JR, Bander NH. Tagawa ST, et al. Among authors: osborne jr. J Clin Oncol. 2024 Mar 1;42(7):842-851. doi: 10.1200/JCO.23.00573. Epub 2023 Nov 3. J Clin Oncol. 2024. PMID: 37922438 Free PMC article. Clinical Trial.
Guest Editorial.
Osborne JR. Osborne JR. Semin Nucl Med. 2016 Jan;46(1):3-4. doi: 10.1053/j.semnuclmed.2015.10.002. Semin Nucl Med. 2016. PMID: 26687852 No abstract available.
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas.
Ivanidze J, Chang SJ, Haghdel A, Kim JT, Roy Choudhury A, Wu A, Ramakrishna R, Schwartz TH, Cisse B, Stieg P, Muller L, Osborne JR, Magge RS, Karakatsanis NA, Roytman M, Lin E, Pannullo SC, Palmer JD, Knisely JPS. Ivanidze J, et al. Among authors: osborne jr. Neuro Oncol. 2024 Aug 5;26(8):1526-1535. doi: 10.1093/neuonc/noae067. Neuro Oncol. 2024. PMID: 38553990 Free PMC article. Clinical Trial.
221 results